$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
继发于克唑替尼治疗的重度食管炎:肺癌患者用药后千万不要这样做
2025-10-19 11:44:20
Check Details
阿法替尼用于晚期经治非小细胞肺癌——加拿大真实世界数据
2025-10-19 11:44:20
Check Details
克唑替尼相关肾囊肿:发病率和演化模式
2025-10-19 11:44:20
Check Details
口服克唑替尼在实体瘤患儿中的首剂和稳态药代动力学
2025-10-19 11:44:20
Check Details
酪氨酸激酶抑制剂一线治疗罕见EGFR突变肺腺癌:老年患者无进展生存期更长
2025-10-19 11:44:20
Check Details
克唑替尼对中国晚期ALK+肺癌脑转移的疗效:真实世界临床数据
2025-10-19 11:44:20
Check Details
阿法替尼或厄洛替尼一线治疗EGFR+肺癌的治疗时间
2025-10-19 11:44:20
Check Details
舒尼替尼改善小细胞肺癌患者生存期
2025-10-19 11:44:20
Check Details
艾乐替尼使肺癌患者脑转移风险下降
2025-10-19 11:44:20
Check Details
色瑞替尼延长肺癌患者生存期
2025-10-19 11:44:20
Check Details
奥希替尼治疗T790M突变阳性晚期非小细胞肺癌
2025-10-19 11:44:20
Check Details
阿法替尼一线治疗肺癌的疗效
2025-10-19 11:44:20
Check Details
1
2
...
9088
9089
9090
9091
9092
9093
9094
...
10212
10213
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
2
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
3
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
4
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
5
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
6
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
7
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
8
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages
9
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
10
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management
11
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
12
Complete Guide to Dosage and Dose Adjustment of Entrectinib